Home / Resources / On-Demand Webinar / Strengths and opportunities for HTAs and market access in Europe through case studies
Strengths and opportunities for HTAs and market access in Europe through case studies

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the largest and potentially the most comprehensive healthcare data resource, covering ~65 million lives, more than 99% of the French population and about 10% of Europe.

In this short video by Nadia Quignot, Director, Decision Analytics & Real World Evidence at Certara as she discusses strengths and opportunities for HTAs and market access in Europe through case studies.

About Our Speaker

Nadia Quignot is Director, Real World Data solutions & Data analytics at Certara. Over the last >12 years, Nadia has worked on the development of methods to inform risk and benefit/risk assessment and has coordinated a range of (real world) data analytics projects, for European bodies and pharma companies. As a safety scientist at Roche Pharma, she was in charge of risk and benefit/risk evaluations for anti-inflammatory and anti-cancer drugs. In the R&D projects she conducted for European bodies, she was particularly involved in hazard characterization of drugs, pesticides and other food-related and environmental contaminants.

Back to top